<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20170531034272N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-07-24</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Efficacy of Maggot therapy on burning ulcers</public_title>
      <acronym></acronym>
      <scientific_title>A clinical study on efficacy of maggot therapy for treatment of 3rd grade of burning ulcers</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-08-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>24</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/31116</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: A complete randomized design will conduct for categorizing of 24 of volunteer patients into two groups, control and treatment. Six possible arrangements of A and B will type on six cards including AABB, ABBA, BBAA, ABAB, BABA, BAAB. All cards will put in a box with shuffling. Dice will select a card for each time of categorizing. Each time of categorizing will appear the category of four patients to A (for control group) and B (for treatment group. Each card will return to box for next dicing. After 6 time of categorizing the 24 cases will categorize as control or treatment group.</study_design>
      <phase>3</phase>
      <hc_freetext>Burning ulcers of grade 3.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Maggot therapy (use of larvae of Lucilia sericata) will use beside of routine therapeutic measures.  Routine therapy may be involves local and systemic measures, various kinds of surgery, debridement, various kinds of dressing, nutritional support, and antibiotic and other pharmaceutic therapy. The number of larvae per wound in order to maggot therapy varies depending on the extent and depth of the wound and infection in different parts of the wound. A range of 8 to 10 larvae per cm2 of ulcer will use. Interventions will be done every 48 hours. Outcomes of the study (bacterial infections and extend of necrotic and granulated tissues) will be surveyed every 48 hours on the wounds. In this study, the duration of the intervention will be until complete remove of the necrotic tissue. Intervention 2: Control group: Patients of this group will receive routine therapy which may be involves local and systemic measures, various kinds of surgery, debridement, various kinds of dressing, nutritional support, and antibiotic and other pharmaceutic therapy. Outcomes of the study (bacterial infections and extend of necrotic and granulated tissues) will be surveyed every 48 hours on the wounds. In this study, the patients of control group will be under supervisions until complete remove of the necrotic tissue.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Data and documents about main outcome and secondary outcome

When:
starting 3 months after publication

To whom:
for all involving people

Conditions:
University teachers and researchers can request data via personal contact and they can use them for their lectures and teaching sessions. Using the data in advertisements and public broadcasting such as printed materials and so on should be arranged formally with Tehran University of Medical Sciences.

Where to obtain:
- from website of Tehran University of Medical Sciences
- from website of Shahid Motahhari Hospital of Tehran
- from webpages of involved researchers

How to obtain:
- Sending email to kakbarzadeh@tums.ac.ir
- Sending email to jrafinejad@tums.ac.ir

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Javad Rafinejad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Enghelab Street, Ghods Street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>14155-6446</zip>
        <telephone>+98 21 4293 3121</telephone>
        <email>jrafinejad@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Kamran Akbarzadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Medical Entomology, School of Public Health, Tehran University of Medical Sciences</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1417613151</zip>
        <telephone>+98 21 4293 3111</telephone>
        <email>kakbarzadeh@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients who have at least one burning ulcer (3rd grade) with bacterial infection.
Patients who have not need anticoagulant or steroid pharmaceutics.
Patients who have not acute or other chronic diseases.
Patients who have ُnot addicted to alcohol or opium.
Patients who have not Osteomyelitis.
Patients who have not entomophobia.</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients who have sever diseases such as heart disorders and so on during maggot Therapy.
Patients who get sever and un-controlled fever during maggot therapy.
Patients who have sever pain during maggot Therapy.
Patients with maceration around the wound after each interval of maggot therapy.
Patients who take bleeding during maggot therapy.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>T21-25</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Burn and corrosion of trunk, shoulder and upper limb, wrist and hand, hip and lower limb, ankle and foot</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Maggot therapy (use of larvae of Lucilia sericata) will use beside of routine therapeutic measures.  Routine therapy may be involves local and systemic measures, various kinds of surgery, debridement, various kinds of dressing, nutritional support, and antibiotic and other pharmaceutic therapy. The number of larvae per wound in order to maggot therapy varies depending on the extent and depth of the wound and infection in different parts of the wound. A range of 8 to 10 larvae per cm2 of ulcer will use. Interventions will be done every 48 hours. Outcomes of the study (bacterial infections and extend of necrotic and granulated tissues) will be surveyed every 48 hours on the wounds. In this study, the duration of the intervention will be until complete remove of the necrotic tissue.</i_keyword>
      <i_keyword>Control group: Patients of this group will receive routine therapy which may be involves local and systemic measures, various kinds of surgery, debridement, various kinds of dressing, nutritional support, and antibiotic and other pharmaceutic therapy. Outcomes of the study (bacterial infections and extend of necrotic and granulated tissues) will be surveyed every 48 hours on the wounds. In this study, the patients of control group will be under supervisions until complete remove of the necrotic tissue.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Measuring the necrotic tissues. Timepoint: 48 and 96 hours after starting of treatment. Method of measurement: Photographing and measuring by MATLAB 1.6, the mathwork inc, natic, ma, 2000.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Bacterial infections, Staphilococcus aureus and Pseudomonas aeruginosa. Timepoint: 48 and 96 hours after treatment. Method of measurement: culturing of samples in laboratory.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-03-04</approval_date>
        <contact_name>Ethical Committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>ٍEnghelab Street, Ghods Street Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
